{"id":"gadolinium","rwe":[],"_fda":{"id":"28bfacec-d5ea-4620-86c1-76c2d6200295","set_id":"07a457c0-df0d-468a-b0d8-84c739c17b70","openfda":{"nui":["N0000175771","N0000193962","N0000175731","N0000175770","N0000185508","N0000175629","N0000184306","M0000728","M0005152","N0000175831","N0000008595","N0000008924","N0000175830"],"unii":["CPD4NFA903","DIF093I037","F79059A38U","S7V92P67HO","6P669D8HQ8","OW5102UV6N","U015TT5I8H","N9E3X5056Q","E211KPY694","SBV4XY874G","00BH33GNGH","30K4522N6T","GNR9HML8BA","0R0008Q3JB","3Y5X6RT823","OVP6XX033E","3G0H8C9362","Q28R5GF371","789U1901C5","1D4N45714Q","77B218D3YE","514B9K0L10","444W947O8O","AU0V1LM3JT","639KR60Q1Q","96WE91N25T","79Y1949PYO","W1XX32SQN1","2A26YW7PNX","045A6V3VFX","P483J7GX6D","34C49NV47P","TBV2PPG6EF","H2198F8ZNA","E1UOL152H7","6I3K30563S","XJJ7QA858R","2P299V784P","2BMD2GNA4V","C88X29Y479","I38ZP9992A","42Z2K6ZL8P","HT3R7C012Q","324Y4038G2","81AH48963U","AYT3H319PN","7OV03QG267","05175J654G","2E7M255OPY","5TWQ1V240M","27YLU75U4W","49DFR088MY","FZJ641678T","NKN7EZA750","56X6LID5ZY","11T9HCO30O","LZB7TFX1LT","Y793W5V55N","DMK383DSAC","93722E7JA1","760T5R8B3O","42OD65L39F","H6241UJ22B","3M4G523W1G","41YPU4MMCA","6424HBN274","06SSF7P179","AD84R52XLF","387GMG9FH5","6IO182RP7A","3V057702FY","00J9J9XKDE","T66CZ53RP4","J41CSQ7QDS"],"route":["ORAL"],"spl_id":["28bfacec-d5ea-4620-86c1-76c2d6200295"],"brand_name":["Neurotox"],"spl_set_id":["07a457c0-df0d-468a-b0d8-84c739c17b70"],"package_ndc":["43857-0632-1"],"product_ndc":["43857-0632"],"generic_name":["AGARICUS MUSCARIUS, COCCUS CACTI, CONIUM MACULATUM, LYCOPODIUM CLAVATUM, PHOSPHORUS, ALUMINIUM METALLICUM, ANTIMONIUM CRUDUM, ARGENTUM METALLICUM, ARSENICUM ALBUM, AURUM METALLICUM, BARYTA CARBONICA, BERYLLIUM METALLICUM, BISMUTHUM METALLICUM, BORON, BROMIUM, CADMIUM METALLICUM, CERIUM METALLICUM, CESIUM CHLORIDE, CHROMIUM, COBALTUM METALLICUM, CUPRUM METALLICUM, DYSPROSIUM METALLICUM, ERBIUM METALLICUM, EUROPIUM METALLICUM, FERRUM METALLICUM, GADOLINIUM METALLICUM, GERMANIUM SESQUIOXIDE,"],"product_type":["HUMAN OTC DRUG"],"pharm_class_cs":["Allergens [CS]","Copper [CS]"],"pharm_class_pe":["Neuromuscular Blockade [PE]","Increased Histamine Release [PE]","Cell-mediated Immunity [PE]","Decreased Embryonic Implantation [PE]","Decreased Sperm Motility [PE]","Inhibit Ovum Fertilization [PE]"],"substance_name":["ALUMINUM","AMANITA MUSCARIA FRUITING BODY","ANTIMONY TRISULFIDE","ARSENIC TRIOXIDE","BARIUM CARBONATE","BERYLLIUM","BISMUTH","BORON","BOTULINUM TOXIN TYPE A","BROMINE","CADMIUM","CERIUM","CESIUM CHLORIDE","CHROMIUM","CITHARACANTHUS SPINICRUS","CLOSTRIDIUM PERFRINGENS","COBALT","CONIUM MACULATUM FLOWERING TOP","COPPER","DYSPROSIUM","ERBIUM","ESCHERICHIA COLI","EUROPIUM","GADOLINIUM","GELSEMIUM SEMPERVIRENS ROOT","GERMANIUM SESQUIOXIDE","GOLD","HOLMIUM","HUMAN HERPESVIRUS 4","INDIUM","INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED)","INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED)","INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (UV, FORMALDEHYDE INACTIVATED)","INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED)","IRON","LANTHANUM","LATRODECTUS MACTANS","LEAD","LITHIUM CARBONATE","LYCOPODIUM CLAVATUM SPORE","MAGNESIUM","MANGANESE","MEASLES VIRUS","MERCURIUS SOLUBILIS","MOLYBDENUM","NEODYMIUM OXIDE","NICKEL","NIOBIUM","OSMIUM","PALLADIUM","PHOSPHORUS","PLATINUM","POLIOVIRUS","PRASEODYMIUM","PROTEUS MORGANII","PROTEUS VULGARIS","PROTORTONIA CACTI","PSEUDOMONAS AERUGINOSA","RHODIUM","RUBIDIUM NITRITE","SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI","SAMARIUM","SELENIUM","SILVER","STRONTIUM CARBONATE","TANTALUM","TERBIUM","THALLIUM","TIN","TOXICODENDRON PUBESCENS LEAF","URANYL NITRATE HEXAHYDRATE","VANADIUM","YTTERBIUM OXIDE","ZINC"],"pharm_class_epc":["Acetylcholine Release Inhibitor [EPC]","Neuromuscular Blocker [EPC]","Standardized Chemical Allergen [EPC]","Copper-containing Intrauterine Device [EPC]"],"pharm_class_moa":["Acetylcholine Release Inhibitors [MoA]"],"manufacturer_name":["BioActive Nutritional, Inc."],"is_original_packager":[true]},"purpose":["PURPOSE: For temporary relief of symptoms due to numbness, tingling, muscle cramps, and nerve pain."],"version":"2","warnings":["WARNINGS: If pregnant or breast-feeding, ask a health care professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Do not use if tamper evident seal is broken or missing. Store in cool, dry place."],"questions":["QUESTIONS: Distributed by: BioActive Nutritional, Inc. 1803 N. Wickham Rd. Melbourne, FL 32935 bioactivenutritional.com"],"effective_time":"20250519","active_ingredient":["ACTIVE INGREDIENTS: Agaricus Muscarius 12X, Coccus Cacti 12X, Conium Maculatum 12X, Lycopodium Clavatum 12X, Phosphorus 12X, Aluminium Metallicum 12X, 30X, Antimonium Crudum 12X, 30X, Argentum Metallicum 12X, 30X, Arsenicum Album 12X, 30X, Aurum Metallicum 12X, 30X, Baryta Carbonica 12X, 30X, Beryllium Metallicum 12X, 30X, Bismuthum Metallicum 12X, 30X, Boron 12X, 30X, Bromium 12X, 30X, Cadmium Metallicum 12X, 30X, Cerium Metallicum 12X, 30X, Cesium Chloride 12X, 30X, Chromium 12X, 30X, Cobaltum Metallicum 12X, 30X, Cuprum Metallicum 12X, 30X, Dysprosium Metallicum 12X, 30X, Erbium Metallicum 12X, 30X, Europium Metallicum 12X, 30X, Ferrum Metallicum 12X, 30X, Gadolinium Metallicum 12X, 30X, Germanium Sesquioxide 12X, 30X, Holmium Metallicum 12X, 30X, Indium Metallicum 12X, 30X, Lithium Carbonicum 12X, 30X, Magnesium Metallicum 12X, 30X, Manganum Metallicum 12X, 30X, Mercurius Solubilis 12X, 30X, Molybdenum 12X, 30X, Neodymium Oxide 12X, 30X, Niccolum Metallicum 12X, 30X, Osmium Metallicum 12X, 30X, Palladium Metallicum 12X, 30X, Platinum Metallicum 12X, 30X, Plumbum Metallicum 12X, 30X, Praseodymium Metallicum 12X, 30X, Rhodium Metallicum 12X, 30X, Rubidium Nitricum 12X, 30X, Samarium Metallicum 12X, 30X, Selenium Metallicum 12X, 30X, Stannum Metallicum 12X, 30X, Strontium Carbonicum 12X, 30X, Terbium Metallicum 12X, 30X, Thallium Metallicum 12X, 30X, Uranium Nitricum 12X, 30X, Vanadium Metallicum 12X, 30X, Ytterbium Oxide 12X, 30X, Zincum Metallicum 12X, 30X, Gelsemium Sempervirens 30X, Influenzinum 30X, Latrodectus Mactans 30X, Morbillinum 30X, Rhus Tox 30X, Tarentula Cubensis 30X, Botulinum 30X, 60X, Escherichia Coli Colibacillinum Cum Natrum Muriaticum 30X, 60X, Proteus (Vulgaris) 30X, 60X, Pseudomonas Aeruginosa 30X, 60X, Proteus (Morgani) 30X, 60X, Salmonella Typhi Nosode 33X, Lanthanum Metallicum 14C, Clostridium Perfringens 15C, 30C, Epstein-Barr Virus Nosode 30C, Niobium Metallicum 30C, Poliomyelitis Nosode 30C, Tantalum Metallicum 30C."],"inactive_ingredient":["INACTIVE INGREDIENTS: Demineralized Water, 25% Ethanol"],"indications_and_usage":["INDICATIONS: For temporary relief of symptoms due to numbness, tingling, muscle cramps, and nerve pain."],"dosage_and_administration":["DIRECTIONS: 10 drops orally, 3 times a day. Consult a physician for use in children under 12 years of age."],"spl_product_data_elements":["Neurotox Agaricus Muscarius, Coccus Cacti, Conium Maculatum, Lycopodium Clavatum, Phosphorus, Aluminium Metallicum, Antimonium Crudum, Argentum Metallicum, Arsenicum Album, Aurum Metallicum, Baryta Carbonica, Beryllium Metallicum, Bismuthum Metallicum, Boron, Bromium, Cadmium Metallicum, Cerium Metallicum, Cesium Chloride, Chromium, Cobaltum Metallicum, Cuprum Metallicum, Dysprosium Metallicum, Erbium Metallicum, Europium Metallicum, Ferrum Metallicum, Gadolinium Metallicum, Germanium Sesquioxide, AMANITA MUSCARIA FRUITING BODY AMANITA MUSCARIA FRUITING BODY PROTORTONIA CACTI PROTORTONIA CACTI CONIUM MACULATUM FLOWERING TOP CONIUM MACULATUM FLOWERING TOP LYCOPODIUM CLAVATUM SPORE LYCOPODIUM CLAVATUM SPORE PHOSPHORUS PHOSPHORUS ALUMINUM ALUMINUM ANTIMONY TRISULFIDE ANTIMONY TRISULFIDE SILVER SILVER ARSENIC TRIOXIDE ARSENIC CATION (3+) GOLD GOLD BARIUM CARBONATE BARIUM CATION BERYLLIUM BERYLLIUM BISMUTH BISMUTH BORON BORON BROMINE BROMINE CADMIUM CADMIUM CERIUM CERIUM CESIUM CHLORIDE CESIUM CATION CHROMIUM CHROMIUM COBALT COBALT COPPER COPPER DYSPROSIUM DYSPROSIUM ERBIUM ERBIUM EUROPIUM EUROPIUM IRON IRON GADOLINIUM GADOLINIUM GERMANIUM SESQUIOXIDE GERMANIUM SESQUIOXIDE HOLMIUM HOLMIUM INDIUM INDIUM LITHIUM CARBONATE LITHIUM CATION MAGNESIUM MAGNESIUM MANGANESE MANGANESE MERCURIUS SOLUBILIS MERCURIUS SOLUBILIS MOLYBDENUM MOLYBDENUM NEODYMIUM OXIDE NEODYMIUM OXIDE NICKEL NICKEL OSMIUM OSMIUM PALLADIUM PALLADIUM PLATINUM PLATINUM LEAD LEAD PRASEODYMIUM PRASEODYMIUM RHODIUM RHODIUM RUBIDIUM NITRITE RUBIDIUM CATION NITRITE ION SAMARIUM SAMARIUM SELENIUM SELENIUM TIN TIN STRONTIUM CARBONATE STRONTIUM CATION TERBIUM TERBIUM THALLIUM THALLIUM URANYL NITRATE HEXAHYDRATE URANIUM CATION (6+) VANADIUM VANADIUM YTTERBIUM OXIDE YTTERBIUM OXIDE ZINC ZINC GELSEMIUM SEMPERVIRENS ROOT GELSEMIUM SEMPERVIRENS ROOT INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED) INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED) INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED) INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED) INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (UV, FORMALDEHYDE INACTIVATED) INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED) INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED) INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED) LATRODECTUS MACTANS LATRODECTUS MACTANS MEASLES VIRUS MEASLES VIRUS TOXICODENDRON PUBESCENS LEAF TOXICODENDRON PUBESCENS LEAF CITHARACANTHUS SPINICRUS CITHARACANTHUS SPINICRUS BOTULINUM TOXIN TYPE A BOTULINUM TOXIN TYPE A ESCHERICHIA COLI ESCHERICHIA COLI PROTEUS VULGARIS PROTEUS VULGARIS PSEUDOMONAS AERUGINOSA PSEUDOMONAS AERUGINOSA PROTEUS MORGANII PROTEUS MORGANII SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI SALMONELLA ENTERICA ENTERICA SEROVAR TYPHI LANTHANUM LANTHANUM CLOSTRIDIUM PERFRINGENS CLOSTRIDIUM PERFRINGENS HUMAN HERPESVIRUS 4 HUMAN HERPESVIRUS 4 NIOBIUM NIOBIUM POLIOVIRUS POLIOVIRUS TANTALUM TANTALUM WATER ALCOHOL"],"keep_out_of_reach_of_children":["KEEP OUT OF REACH OF CHILDREN: In case of overdose, get medical help or contact a Poison Control Center right away."],"package_label_principal_display_panel":["PACKAGE LABEL DISPLAY: BIO Active Nutritional NEUROTOX HOMEOPATHIC 2 FL OZ (60 ml) NEUROTOX"]},"tags":[{"label":"Acetylcholine Release Inhibitor [EPC]","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Oral","category":"route"},{"label":"Active","category":"status"},{"label":"numbness","category":"indication"},{"label":"tingling","category":"indication"},{"label":"muscle cramps","category":"indication"},{"label":"nerve pain","category":"indication"},{"label":"BioActive Nutritional, Inc.","category":"company"}],"phase":"marketed","safety":{"boxedWarnings":[]},"trials":[],"aliases":[],"company":"BioActive Nutritional, Inc.","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=GADOLINIUM","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:18:09.878085+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:18:15.754425+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=GADOLINIUM","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:18:16.114294+00:00"},"mechanism.drugClass":{"url":"https://api.fda.gov/drug/label.json","method":"deterministic","source":"FDA Label (EPC)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T00:18:08.620606+00:00"},"administration.route":{"url":"","method":"deterministic","source":"FDA Label","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T00:18:08.620641+00:00"},"safety.boxedWarnings":{"url":"","method":"deterministic","source":"FDA Label (no boxed warning)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T00:18:08.620649+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Ribonucleoside-diphosphate reductase RR1 inhibitor","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:18:17.174215+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3544910/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:18:16.819627+00:00"}},"allNames":"neurotox","offLabel":[],"synonyms":["Neurotox","ALUMINUM"],"timeline":[],"approvals":[],"brandName":"Neurotox","ecosystem":[],"mechanism":{"moaClass":"Acetylcholine Release Inhibitors [MoA]","modality":"Small Molecule","drugClass":"Acetylcholine Release Inhibitor [EPC]","explanation":"","oneSentence":"","technicalDetail":"Neurotox acts as an acetylcholine release inhibitor, likely by binding to and blocking the vesicular acetylcholine transporter (VACHT), which is responsible for packaging and releasing acetylcholine from nerve terminals."},"commercial":{},"references":[{"id":1,"url":"https://api.fda.gov/drug/label.json?search=openfda.generic_name:\"GADOLINIUM\"","fields":["mechanism","indications","adverse_reactions","contraindications","warnings","dosage"],"source":"OpenFDA Label"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=gadolinium","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=gadolinium","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-31T10:33:49.412518","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:18:18.867312+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[],"genericName":"gadolinium","indications":{"approved":[{"name":"numbness","source":"OpenFDA Label","regulator":"FDA"},{"name":"tingling","source":"OpenFDA Label","regulator":"FDA"},{"name":"muscle cramps","source":"OpenFDA Label","regulator":"FDA"},{"name":"nerve pain","source":"OpenFDA Label","regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT06220669","phase":"PHASE2","title":"A Study of LY3541860 in Adult Participants With Relapsing Multiple Sclerosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2024-03-19","conditions":["Multiple Sclerosis"],"enrollment":63,"completionDate":"2026-07"},{"nctId":"NCT01130545","phase":"","title":"Imaging Techniques in MRI","status":"RECRUITING","sponsor":"National Institutes of Health Clinical Center (CC)","startDate":"2010-06-05","conditions":["Cardiac Risk Factors","Healthy","Healthy Volunteers"],"enrollment":1000,"completionDate":""},{"nctId":"NCT06280781","phase":"NA","title":"Imperial Prostate 9 - ATLAS (Approaches To Long-Term Active Surveillance)","status":"RECRUITING","sponsor":"Imperial College London","startDate":"2024-05-24","conditions":["Prostate Cancer"],"enrollment":1263,"completionDate":"2032-06"},{"nctId":"NCT07296263","phase":"NA","title":"Evaluation of Gadolinium Based Contrast Agents for Portable MR Imaging Systems","status":"RECRUITING","sponsor":"Hyperfine","startDate":"2025-12-30","conditions":["Intra-axial Tumors","Extra-axial Tumors","Infection/Inflammatory Lesions"],"enrollment":85,"completionDate":"2026-10-31"},{"nctId":"NCT02531880","phase":"PHASE1","title":"Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy","status":"RECRUITING","sponsor":"National Institute of Neurological Disorders and Stroke (NINDS)","startDate":"2024-11-19","conditions":["Epilepsy"],"enrollment":40,"completionDate":"2026-07-01"},{"nctId":"NCT04712552","phase":"","title":"In Vivo Measurement of the Accuracy of the \"Neurolocate\" Module of the Neurosurgical Robot \"Neuromate\" in Its Application to Deep Brain Stimulation","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nice","startDate":"2021-01-26","conditions":["Parkinson Disease","Dystonia","Tremor"],"enrollment":18,"completionDate":"2023-01-07"},{"nctId":"NCT05692635","phase":"PHASE2","title":"Reducing the Incidence of Symptomatic Brain Metastases With MRI Surveillance","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2023-08-30","conditions":["Brain Metastases","Nonsmall Cell Lung Cancer Stage III"],"enrollment":60,"completionDate":"2028-04"},{"nctId":"NCT04899908","phase":"PHASE2","title":"Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2021-09-15","conditions":["Brain Cancer","Brain Metastases","Melanoma","Lung Cancer","Breast Cancer","HER2-positive Breast Cancer","Colorectal Cancer","Gastrointestinal Cancer","SRS","SRT","Whole Brain Radiation","Stereotactic Radiation","AGuIX","Nanoparticle","Cystic","Brain Tumor"],"enrollment":134,"completionDate":"2029-05"},{"nctId":"NCT04931368","phase":"PHASE3","title":"OptiMATe: De-escalated Induction Treatment in Primary CNS Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Klinikum Stuttgart","startDate":"2021-06-28","conditions":["Primary Central Nervous System Lymphoma"],"enrollment":331,"completionDate":"2028-11"},{"nctId":"NCT03581318","phase":"","title":"Technical and Translational Development of Cardiovascular Magnetic Resonance (CMR) Imaging","status":"RECRUITING","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2018-07-12","conditions":["Normal and Abnormal Cardiovascular Physiology"],"enrollment":5000,"completionDate":"2028-04-01"},{"nctId":"NCT03730051","phase":"PHASE4","title":"Dotarem vs Gadobutrol Contrast for Breast MRI","status":"COMPLETED","sponsor":"University of Massachusetts, Worcester","startDate":"2021-03-01","conditions":["Breast Diseases"],"enrollment":300,"completionDate":"2025-12-31"},{"nctId":"NCT06151223","phase":"","title":"A Prospective Registry for Patients at High-Risk for Pancreatic Cancer","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2021-07-13","conditions":["Pancreatic Cancer","Pancreatic Ductal Adenocarcinoma","PDAC","PDAC - Pancreatic Ductal Adenocarcinoma"],"enrollment":5000,"completionDate":"2031-07-31"},{"nctId":"NCT03067467","phase":"","title":"Metabolic Characteristics of Brain Tumors Using Hyperpolarized Carbon-13 Magnetic Resonance Spectroscopic Imaging (MRSI)","status":"RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2019-06-01","conditions":["Brain Tumor Adult"],"enrollment":25,"completionDate":"2026-12-31"},{"nctId":"NCT01092949","phase":"","title":"Reference Ranges for Placental Perfusion Using Magnetic Resonance Imaging (MRI)PLACENTIMAGE","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2010-02","conditions":["Placental Insufficiency"],"enrollment":135,"completionDate":"2018-09"},{"nctId":"NCT06330805","phase":"PHASE2","title":"Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer","status":"RECRUITING","sponsor":"Ohio State University Comprehensive Cancer Center","startDate":"2024-08-12","conditions":["Prostate Adenocarcinoma","Stage IIB Prostate Cancer AJCC v8","Stage IIC Prostate Cancer AJCC v8"],"enrollment":70,"completionDate":"2027-12-31"},{"nctId":"NCT06280742","phase":"NA","title":"Study of Neuroinflammation in Multiple Sclerosis by PET-MRI Imaging Using the Radiotracer ([18F]-DPA-714) : a Multicentre Cohort Study (INFLANET)","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-12-16","conditions":["Multiple Sclerosis"],"enrollment":41,"completionDate":"2028-12"},{"nctId":"NCT04454450","phase":"NA","title":"Using Advanced Imaging Studies to Develop a Profile of High-grade Serous Ovarian Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2020-06-22","conditions":["Ovarian Cancer","High Grade Ovarian Serous"],"enrollment":10,"completionDate":"2026-06"},{"nctId":"NCT04769310","phase":"NA","title":"Advanced Cardiac Imaging To Predict Embolic Stroke On Brain MRI: A Pilot Study","status":"COMPLETED","sponsor":"Tulane University","startDate":"2021-04-26","conditions":["Atrial Fibrillation","Stroke","Stroke, Cardiovascular","Vascular Cognitive Impairment","Strokes Thrombotic","Stroke, Ischemic"],"enrollment":5,"completionDate":"2026-01-27"},{"nctId":"NCT04819737","phase":"NA","title":"Spinal Cord Lesion Detection in Multiple Sclerosis Using Novel MRI Sequences","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2022-07-18","conditions":["Multiple Sclerosis (MS)"],"enrollment":10,"completionDate":"2027-12"},{"nctId":"NCT04657835","phase":"NA","title":"Multiparametric MRI Assessment of Atrial Heart Disease as a Predictor of Atrial Fibrillation After Myocardial Revascularization Surgery","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2026-05-01","conditions":["Postoperative Atrial Fibrillation"],"enrollment":100,"completionDate":"2028-12"},{"nctId":"NCT04814420","phase":"NA","title":"Atrial Fibrosis in Obstructive Sleep Apnea Patients: A Pilot Study","status":"RECRUITING","sponsor":"Tulane University","startDate":"2021-07-12","conditions":["Atrial Fibrillation","Obstructive Sleep Apnea"],"enrollment":60,"completionDate":"2026-07"},{"nctId":"NCT04867954","phase":"","title":"Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis","status":"RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2021-10-28","conditions":["Cirrhosis, Liver","Gastroesophageal Varices","Fontan Procedure"],"enrollment":146,"completionDate":"2026-04"},{"nctId":"NCT05849467","phase":"PHASE1","title":"Central Nervous System Uptake of Anti-CD8+ T Cell Minibodies in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy","status":"RECRUITING","sponsor":"National Institute of Neurological Disorders and Stroke (NINDS)","startDate":"2023-10-19","conditions":["Multiple Sclerosis","Progressive Multifocal Leukoencephalopathy"],"enrollment":15,"completionDate":"2026-06-30"},{"nctId":"NCT03331380","phase":"NA","title":"Technical Development of Cardiovascular Magnetic Resonance Imaging (CMR) Using a Low Specific Absorption Rate (SAR) Scanner System","status":"RECRUITING","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2018-01-05","conditions":["CAD"],"enrollment":2950,"completionDate":"2026-05-31"},{"nctId":"NCT07436962","phase":"NA","title":"Loop Recorder Implantation in Patients With Mitral Annular Disjunction","status":"RECRUITING","sponsor":"Gottsegen National Cardiovascular Institute","startDate":"2025-12-05","conditions":["Mitral Annular Disjunction","Mitral Valve","Arrhythmia Ventricular","Sudden Cardiac Death Due to Cardiac Arrhythmia","Loop Recorder"],"enrollment":20,"completionDate":"2030-02"},{"nctId":"NCT06319027","phase":"PHASE2","title":"Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial","status":"RECRUITING","sponsor":"ECOG-ACRIN Cancer Research Group","startDate":"2024-04-11","conditions":["Glioblastoma, IDH-Wildtype"],"enrollment":100,"completionDate":"2027-05-31"},{"nctId":"NCT05263804","phase":"NA","title":"CoHort of Patients to Identify Biological and Imaging markerS of CardiovascUlar Outcomes in Stroke - HIBISCUS-STROKE II","status":"RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2022-05-22","conditions":["Ischemic Stroke"],"enrollment":500,"completionDate":"2029-06"},{"nctId":"NCT03270059","phase":"PHASE2","title":"Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System","status":"RECRUITING","sponsor":"OHSU Knight Cancer Institute","startDate":"2017-10-06","conditions":["Central Nervous System Neoplasm","Cranial Nerve Disorder","Metastatic Malignant Neoplasm in the Brain"],"enrollment":150,"completionDate":"2028-12-15"},{"nctId":"NCT05855746","phase":"PHASE3","title":"Colchicine Versus Placebo in Acute Myocarditis Patients","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-07-16","conditions":["Acute Myocarditis"],"enrollment":300,"completionDate":"2028-07-16"},{"nctId":"NCT07428031","phase":"","title":"French Registry: Late Gadolinium Enhancement in Hypertrophic Cardiomyopathy","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-03-01","conditions":["Cardiomyopathy","Hypertrophic Cardiomyopathies"],"enrollment":5000,"completionDate":"2036-03-01"},{"nctId":"NCT04288323","phase":"PHASE4","title":"Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients With Cirrhosis","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2018-04-27","conditions":["Liver Cancer","Liver Cirrhoses","Liver Carcinoma"],"enrollment":79,"completionDate":"2025-12-16"},{"nctId":"NCT07399327","phase":"NA","title":"Biomarkers of Response to SEEG Thermocoagulation","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2026-03-01","conditions":["Drug Resistant Epilepsy"],"enrollment":45,"completionDate":"2029-06-30"},{"nctId":"NCT01237054","phase":"PHASE2","title":"Imaging in MGUS, SMM and MM","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2010-10-17","conditions":["Multiple Myeloma","Smoldering Multiple Myeloma","Monoclonal Gammopathy of Undetermined Significance"],"enrollment":31,"completionDate":"2011-08-09"},{"nctId":"NCT07394543","phase":"","title":"French Registry of CMR Late Gadolinium Enhancement in Myocarditis","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-02-10","conditions":["Myocarditis Acute"],"enrollment":5000,"completionDate":"2036-02-10"},{"nctId":"NCT07275814","phase":"PHASE3","title":"A Study of a Gadolinium-Based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Central Nervous System (CNS) Lesions","status":"RECRUITING","sponsor":"Shanghai Shengdi Pharmaceutical Co., Ltd","startDate":"2025-11-17","conditions":["For Contrast-enhanced Magnetic Resonance Imaging (MRI) of Central Nervous System (CNS) Lesions"],"enrollment":250,"completionDate":"2026-05"},{"nctId":"NCT05794022","phase":"NA","title":"Cohort of STEMI Patients 2","status":"RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2023-05-03","conditions":["Myocardial Infarction"],"enrollment":300,"completionDate":"2031-06-03"},{"nctId":"NCT07272616","phase":"","title":"Detection of Brain Metastases Using a Novel Gadolinium-Weighted MRI Sequence: A Prospective Comparison","status":"RECRUITING","sponsor":"Region Stockholm","startDate":"2026-01-28","conditions":["Brain Neoplasms"],"enrollment":100,"completionDate":"2027-12-31"},{"nctId":"NCT02648009","phase":"PHASE1","title":"Metabolic Imaging of the Heart Using Hyperpolarized (13C) Pyruvate Injection","status":"RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2016-04","conditions":["Hypertension","Hypertrophy"],"enrollment":112,"completionDate":"2027-04"},{"nctId":"NCT05763615","phase":"NA","title":"3D Modeling of the Cervico-facial Region and Cranial Nerve Tractography: IMAG 2 ORL Project","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-05-10","conditions":["Head and Neck Neoplasms","Congenital Abnormalities"],"enrollment":7,"completionDate":"2024-05-04"},{"nctId":"NCT02649985","phase":"PHASE1,PHASE2","title":"PET Brain Imaging in Multiple Sclerosis, Alzheimer's Disease, and Other Neurological and Neuropsychiatric Diseases","status":"RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2016-05-02","conditions":["Multiple Sclerosis","Alzheimer's Disease"],"enrollment":250,"completionDate":"2027-12-31"},{"nctId":"NCT04373564","phase":"PHASE4","title":"Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years","status":"RECRUITING","sponsor":"Guerbet","startDate":"2021-03-24","conditions":["Motor Function","Cognitive Function","Contrast Media"],"enrollment":2076,"completionDate":"2028-12-31"},{"nctId":"NCT04340180","phase":"PHASE1","title":"Evaluating the Performance of AI in Evaluating Breast MRI Performed With Dose Reduction","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2021-07-14","conditions":["Breast Benign Tumor","Breast Malignant Tumor"],"enrollment":20,"completionDate":"2026-01-20"},{"nctId":"NCT04251481","phase":"NA","title":"Diffusion MRI for Head and Neck Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"NYU Langone Health","startDate":"2019-10-16","conditions":["Head Cancer Neck"],"enrollment":16,"completionDate":"2026-04-30"},{"nctId":"NCT07354646","phase":"","title":"The Application of T1 Mapping in Real-World","status":"RECRUITING","sponsor":"Chinese Academy of Medical Sciences, Fuwai Hospital","startDate":"2020-03-01","conditions":["Myocardial Infarction (MI)","Hypertrophic Cardiomyopathy (HCM)","Dilated Cardiomyopathy (DCM)","Arrhythmogenic Cardiomyopathy","Myocarditis"],"enrollment":2000,"completionDate":"2026-12-01"},{"nctId":"NCT07351825","phase":"","title":"CMR Prognostic Markers in Ischemic Heart Disease","status":"RECRUITING","sponsor":"Chinese Academy of Medical Sciences, Fuwai Hospital","startDate":"2009-01","conditions":["Ischemic Heart Disease (IHD)","Myocardial Infarction (MI)"],"enrollment":1000,"completionDate":"2035-12"},{"nctId":"NCT07346131","phase":"PHASE4","title":"ELUDYN: Assessment of Intra-individual Variability of Vascular Dynamics of Gadopiclenol Injection Parameters in Contrast-enhanced MRI","status":"RECRUITING","sponsor":"Hôpital Fribourgeois","startDate":"2026-01-07","conditions":["Contrast Agent","Medical Imaging Data","MRI Image Enhancement"],"enrollment":10,"completionDate":"2027-12-31"},{"nctId":"NCT02091518","phase":"NA","title":"Development and Evaluation of Magnetic Resonance Imaging Acquisition and Analysis Methods","status":"ENROLLING_BY_INVITATION","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2014-03","conditions":["Healthy"],"enrollment":461,"completionDate":"2027-09"},{"nctId":"NCT07275723","phase":"PHASE3","title":"A Study of a Gadolinium-Based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Body Parts (Non-Central Nervous System) Lesions","status":"RECRUITING","sponsor":"Shanghai Shengdi Pharmaceutical Co., Ltd","startDate":"2025-11-14","conditions":["For Contrast-enhanced Magnetic Resonance Imaging (MRI) of Abnormal Vascular Lesions in Body Regions Excluding the Central Nervous System (CNS)"],"enrollment":306,"completionDate":"2026-05"},{"nctId":"NCT06731738","phase":"PHASE2","title":"Mangafodipir - an Intracellular Contrast Agent for Magnetic Resonance Imaging (MRI): Measuring Manganese Uptake Rate in Heart Failure Patients With Preserved Ejection Fraction (HFpEF) Patients.","status":"COMPLETED","sponsor":"IC TARGETS AS","startDate":"2024-11-22","conditions":["Heart Failure With Preserved Ejection Fraction (HFPEF)"],"enrollment":44,"completionDate":"2025-11-29"},{"nctId":"NCT04448938","phase":"","title":"RESting-state Functional MRI in Patients With Optic Neuritis for ANticipation of reCovEry","status":"RECRUITING","sponsor":"Fondation Ophtalmologique Adolphe de Rothschild","startDate":"2020-12-17","conditions":["Neuritis"],"enrollment":200,"completionDate":"2027-06"},{"nctId":"NCT04906928","phase":"","title":"Evaluation of New MRI Sequences Including 3D-FGAPSIR for the Optimization of Inflammatory Spinal Cord Lesions Research","status":"RECRUITING","sponsor":"Fondation Ophtalmologique Adolphe de Rothschild","startDate":"2023-10-25","conditions":["Spinal Cord Injuries"],"enrollment":200,"completionDate":"2026-10"},{"nctId":"NCT04906941","phase":"","title":"Assessment of the Impact of Gadolinium Injection on the Measurement of the QSM Signal","status":"COMPLETED","sponsor":"Fondation Ophtalmologique Adolphe de Rothschild","startDate":"2022-01-21","conditions":["White Matter Disease"],"enrollment":73,"completionDate":"2023-07-19"},{"nctId":"NCT04613349","phase":"","title":"FArial NErf MRI in the Preoperative Assessment of PArotide Tumors","status":"RECRUITING","sponsor":"Fondation Ophtalmologique Adolphe de Rothschild","startDate":"2021-01-13","conditions":["Parotid Tumor"],"enrollment":88,"completionDate":"2027-05-13"},{"nctId":"NCT04113395","phase":"","title":"Concordance and Accuracy of MRI in the Detection of Meningiomas: Optimizing Sequences With Low Doses of Gadolinium","status":"COMPLETED","sponsor":"Fondation Ophtalmologique Adolphe de Rothschild","startDate":"2019-12-23","conditions":["Meningioma"],"enrollment":514,"completionDate":"2025-07-18"},{"nctId":"NCT06512558","phase":"NA","title":"Augmented Reality Feasibility for Non-invasive Preoperative Tracking in Breast Cancer Surgery","status":"RECRUITING","sponsor":"Centre Jean Perrin","startDate":"2024-11-14","conditions":["Subclinical Breast Cancer Lesion"],"enrollment":20,"completionDate":"2027-12-01"},{"nctId":"NCT03192891","phase":"","title":"Stress CMR Perfusion Imaging in the United States (SPINS) Study","status":"COMPLETED","sponsor":"Society for Cardiovascular Magnetic Resonance","startDate":"2016-12-01","conditions":["Myocardial Ischemia"],"enrollment":2349,"completionDate":"2019-11-30"},{"nctId":"NCT04474353","phase":"PHASE1","title":"Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma","status":"COMPLETED","sponsor":"Stanford University","startDate":"2021-05-21","conditions":["Glioblastoma","Newly Diagnosed Glioblastoma"],"enrollment":12,"completionDate":"2025-09-02"},{"nctId":"NCT02973633","phase":"EARLY_PHASE1","title":"Diffusion MRI in Heart Failure","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2017-06-30","conditions":["Heart Failure","Myocardial Infarction","Left Ventricular Hypertrophy"],"enrollment":160,"completionDate":"2028-12-31"},{"nctId":"NCT05915728","phase":"PHASE3","title":"A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Any Known or Suspected Problems of the Body (Except Brain or Spinal Cord-related Problems)","status":"COMPLETED","sponsor":"Bayer","startDate":"2023-07-24","conditions":["Contrast Enhancement in Magnetic Resonance Imaging","Non-central Nervous System Pathology"],"enrollment":404,"completionDate":"2024-06-01"},{"nctId":"NCT02156739","phase":"NA","title":"Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2014-10-13","conditions":["Hepatocellular Carcinoma","Liver and Intrahepatic Bile Duct Disorder","Metastatic Malignant Neoplasm in the Liver","Primary Malignant Liver Neoplasm"],"enrollment":100,"completionDate":"2026-06-01"},{"nctId":"NCT02177578","phase":"PHASE2","title":"Subventricular Zone (SVZ) and Temozolomide in Glioblastoma Multiforme","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2014-07-08","conditions":["Glioblastoma Multiforme"],"enrollment":60,"completionDate":"2027-06"},{"nctId":"NCT04566185","phase":"NA","title":"Evaluation of the Predictive Value of 18F-fluorodeoxyglucose Positron Emission Tomography and Brain Perfusion Computed Tomography for the Efficacy of Anti-angiogenic Therapy (Bevacizumab) in Recurrent Glioblastoma","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2020-12-16","conditions":["Glioblastoma"],"enrollment":14,"completionDate":"2023-06-27"},{"nctId":"NCT04369560","phase":"EARLY_PHASE1","title":"Virtual Histology of the Bladder Wall for Bladder Cancer Staging","status":"RECRUITING","sponsor":"Jodi Maranchie","startDate":"2025-05-23","conditions":["Urinary Bladder Neoplasms"],"enrollment":42,"completionDate":"2028-12-30"},{"nctId":"NCT07274397","phase":"NA","title":"Assessment of Early Post-operative Nuclear Imaging in Neurosurgery: a Safety and Feasibility Study in Patients Operated for Glioblastoma","status":"NOT_YET_RECRUITING","sponsor":"Beta Emitting Accurate Monitored Systems","startDate":"2026-01-01","conditions":["Glioblastoma","Brain Tumors","Brain Imaging"],"enrollment":15,"completionDate":"2027-01-01"},{"nctId":"NCT03807765","phase":"PHASE1","title":"Stereotactic Radiation and Nivolumab in the Management of Metastatic Breast Cancer Brain Metastases","status":"COMPLETED","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2019-01-30","conditions":["Metastatic Breast Cancer","Brain Metastases"],"enrollment":14,"completionDate":"2025-03-18"},{"nctId":"NCT07252882","phase":"NA","title":"Interest of Magnetic Resonance Imaging in the Diagnosis of Upper Urinary Tract Invasive Tumours","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Toulouse","startDate":"2025-12-01","conditions":["Magnetic Resonance Imaging (MRI)","Urologic Cancer"],"enrollment":178,"completionDate":"2027-12-31"},{"nctId":"NCT05615415","phase":"","title":"Neuropsychiatric Post-Acute Sequelae of SARS-CoV-2 (PASC) Using TSPO Positron Emission Tomography (PET) and MRI","status":"ACTIVE_NOT_RECRUITING","sponsor":"NYU Langone Health","startDate":"2022-02-15","conditions":["Neuropsychiatric Post-Acute Sequelae of SARS-CoV-2 Infection"],"enrollment":30,"completionDate":"2026-12-31"},{"nctId":"NCT04727242","phase":"PHASE2","title":"CytoreductiveSurgery & HIPEC w/Gemcitabine+Chemotherapy w/Dacarbazine in Uterine Leiomyosarcoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Stanford University","startDate":"2021-01-28","conditions":["LMS - Leiomyosarcoma","Uterine Leiomyosarcoma"],"enrollment":17,"completionDate":"2026-05"},{"nctId":"NCT04126616","phase":"NA","title":"Pulmonary Vascular Impairment in Chronic Obstructive Pulmonary Disease (COPD) Assessed by MRI","status":"COMPLETED","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2019-10-15","conditions":["Chronic Obstructive Pulmonary Disease (COPD)"],"enrollment":30,"completionDate":"2025-10-15"},{"nctId":"NCT02641145","phase":"NA","title":"Molecular Imaging of Primary Amyloid Cardiomyopathy","status":"RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2016-04-01","conditions":["Amyloidosis, Primary","Cardiomyopathy"],"enrollment":171,"completionDate":"2028-12-31"},{"nctId":"NCT05937776","phase":"","title":"Developing a New Metabolic Imaging Approach (aMRI) for Evaluating Neurological Disease in Patients With Gliomas","status":"RECRUITING","sponsor":"OHSU Knight Cancer Institute","startDate":"2023-12-11","conditions":["Glioma"],"enrollment":20,"completionDate":"2025-12-31"},{"nctId":"NCT05307939","phase":"PHASE2","title":"A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2022-03-24","conditions":["HPV","Oropharynx Cancer","HPV-Related Carcinoma","HPV-Related Malignancy","HPV Positive Oropharyngeal Squamous Cell Carcinoma"],"enrollment":30,"completionDate":"2027-03-24"},{"nctId":"NCT02390635","phase":"PHASE1","title":"PET/MRI, 18F-FDG PET/CT and Whole Body MRI in Finding Extramedullary Myeloid Leukemia in Patients With Newly Diagnosed Acute Myeloid Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2020-07-15","conditions":["Acute Myeloid Leukemia","Acute Promyelocytic Leukemia With PML-RARA"],"enrollment":77,"completionDate":"2027-09-15"},{"nctId":"NCT06855628","phase":"PHASE2","title":"Assessment of Novel Metabolic Imaging Modalities as A Predictor Of Therapeutic EfficacyiIn Glioblastoma (GBM)","status":"SUSPENDED","sponsor":"Stanford University","startDate":"2025-01-30","conditions":["Glioma","GBM"],"enrollment":10,"completionDate":"2028-02"},{"nctId":"NCT03345446","phase":"","title":"Circulating RNAs in Acute Congestive Heart Failure","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2016-08-17","conditions":["Acute Congestive Heart Failure","Heart Failure With Reduced Ejection Fraction","Heart Failure With Normal Ejection Fraction"],"enrollment":200,"completionDate":"2026-12-31"},{"nctId":"NCT06226129","phase":"PHASE4","title":"Gadopiclenol in Contrast Enhanced MRI of the Prostate","status":"RECRUITING","sponsor":"Columbia University","startDate":"2024-02-14","conditions":["Prostate Cancer"],"enrollment":150,"completionDate":"2028-02-01"},{"nctId":"NCT06252610","phase":"","title":"PET/MRI of Primary Sclerosing Cholangitis","status":"NOT_YET_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2026-05-10","conditions":["PSC"],"enrollment":10,"completionDate":"2029-04-30"},{"nctId":"NCT03607552","phase":"","title":"Non-contrast DWI for Supplemental Screening","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Washington","startDate":"2018-07-16","conditions":["Breast Cancer"],"enrollment":269,"completionDate":"2029-07"},{"nctId":"NCT06269055","phase":"","title":"Long-term Result of DTPA (Diethylenetriamine Pentaacetate) Chelation for Gadolinium Deposition Disease","status":"RECRUITING","sponsor":"Stanford University","startDate":"2024-12-02","conditions":["Gadolinium Deposition Disease","Ca-DTPA"],"enrollment":50,"completionDate":"2026-05"},{"nctId":"NCT02956291","phase":"NA","title":"Multi-Parametric Quantitative MR Imaging in Evaluation of Brain Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"Case Comprehensive Cancer Center","startDate":"2017-02-15","conditions":["Brain Tumor"],"enrollment":172,"completionDate":"2026-06"},{"nctId":"NCT07206667","phase":"NA","title":"Improved Understanding of Venous Drainage at the Cranio-cervical Junction : Study of Postoperative Venous Remodeling Following Surgical Treatment of Lesions of the Posterior Fossa or Posterior Approach of the Upper Cervical Spine.","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Brest","startDate":"2025-11-03","conditions":["Craniocervical Surgery"],"enrollment":30,"completionDate":"2027-03"},{"nctId":"NCT05783271","phase":"NA","title":"Validity of Parametric MRI Using VIRADS","status":"RECRUITING","sponsor":"Assiut University","startDate":"2025-12-01","conditions":["Bladder Cancer"],"enrollment":58,"completionDate":"2026-12-31"},{"nctId":"NCT06086704","phase":"PHASE2","title":"Study of 18F-FFNP Breast PET/MRI","status":"RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2024-09-25","conditions":["Breast Cancer"],"enrollment":53,"completionDate":"2030-01"},{"nctId":"NCT03743935","phase":"NA","title":"Use of Cardiac MRI in Early Stages of STEMI to Predict Left Ventricular Function Recovery and ICD Implantation","status":"TERMINATED","sponsor":"University Hospital, Montpellier","startDate":"2019-01-07","conditions":["Acute STEMI","Severe Left Ventricular Systolic Dysfunction (Disorder)"],"enrollment":12,"completionDate":"2021-02-22"},{"nctId":"NCT04879628","phase":"PHASE2","title":"Proof-of-concept Study for SAR441344 (Frexalimab) in Relapsing Multiple Sclerosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanofi","startDate":"2021-06-07","conditions":["Multiple Sclerosis"],"enrollment":129,"completionDate":"2027-08-23"},{"nctId":"NCT06265272","phase":"","title":"Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2023-12-10","conditions":["Liver Cirrhosis","Hepatic Cell Carcinoma","Portal Hypertension"],"enrollment":45,"completionDate":"2026-12-19"},{"nctId":"NCT06938074","phase":"NA","title":"Imaging and Treatment Planning for Cardiac Radioablation","status":"NOT_YET_RECRUITING","sponsor":"Stewart Gaede","startDate":"2025-11-01","conditions":["Ventricular Tachycardia, Monomorphic","Ventricular Tachycardia (V-Tach)","Ischemia, Myocardial"],"enrollment":15,"completionDate":"2026-09-01"},{"nctId":"NCT02784210","phase":"PHASE2","title":"Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques","status":"RECRUITING","sponsor":"National Institute of Neurological Disorders and Stroke (NINDS)","startDate":"2016-10-05","conditions":["Multiple Sclerosis"],"enrollment":30,"completionDate":"2028-12-31"},{"nctId":"NCT07185958","phase":"","title":"Dual Energy CT - a Tool for Delineation of Tumor and Organs at Risk in Radiotherapy","status":"NOT_YET_RECRUITING","sponsor":"Aalborg University Hospital","startDate":"2025-09-22","conditions":["Brain Metastases","Bone Metastases","Head and Neck Cancer","Lung Cancer"],"enrollment":80,"completionDate":"2028-03-21"},{"nctId":"NCT02270359","phase":"NA","title":"Research on Infarction With Open Arteries Using OCT and CMR","status":"ACTIVE_NOT_RECRUITING","sponsor":"NYU Langone Health","startDate":"2014-04","conditions":["Myocardial Infarction"],"enrollment":15,"completionDate":"2025-10-31"},{"nctId":"NCT05386043","phase":"","title":"Registering Genomics and Imaging of Tumors (ReGIT)","status":"RECRUITING","sponsor":"Indiana University","startDate":"2023-07-18","conditions":["Glioma"],"enrollment":20,"completionDate":"2032-07-17"},{"nctId":"NCT05237232","phase":"","title":"Modeling of Intracerebral Vascularization After Extracorporeal Membrane Oxygenation in Children","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2022-03-31","conditions":["Extra Corporeal Membrane Oxygenation","Decanulated Alive"],"enrollment":30,"completionDate":"2026-08"},{"nctId":"NCT05419960","phase":"","title":"Audio-vestibular Evaluation of Children and Young Adults With Osteogenesis Imperfecta","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2022-12-22","conditions":["Osteogenesis Imperfecta"],"enrollment":44,"completionDate":"2027-12-22"},{"nctId":"NCT04490785","phase":"NA","title":"Mri characterIzation of Troponin Elevation After Cardiac Surgery","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2020-12-02","conditions":["Cardiac Surgery","Cardiopulmonary Bypass"],"enrollment":38,"completionDate":"2023-01-12"},{"nctId":"NCT03977896","phase":"NA","title":"Feasibility of 11C-MET PET/MRI Imaging in Pediatric Brain Fossa Tumors","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2019-11-03","conditions":["Posterior Brain Fossa Tumors in Children"],"enrollment":15,"completionDate":"2021-11-08"},{"nctId":"NCT02078076","phase":"NA","title":"IRM Cardiaque en Respiration Libre Pour Des Patients Atteints de Dystrophinopathie sévère","status":"COMPLETED","sponsor":"Institut National de la Santé Et de la Recherche Médicale, France","startDate":"2013-06","conditions":["Duchenne or Severe Becker Myopathy"],"enrollment":22,"completionDate":"2015-11"},{"nctId":"NCT04229472","phase":"NA","title":"Characterising the Stable and Dynamic Left Atrial Substrate in Atrial Fibrillation","status":"COMPLETED","sponsor":"Oxford University Hospitals NHS Trust","startDate":"2020-12-07","conditions":["Atrial Fibrillation"],"enrollment":31,"completionDate":"2023-11-02"},{"nctId":"NCT05915702","phase":"PHASE3","title":"A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Known or Suspected Brain or Spinal Cord-related Problems","status":"COMPLETED","sponsor":"Bayer","startDate":"2023-07-24","conditions":["Contrast Enhancement in Magnetic Resonance Imaging","Central Nervous System Pathology"],"enrollment":303,"completionDate":"2024-05-31"},{"nctId":"NCT02184013","phase":"NA","title":"Correlation of the Arrhythmia Mechanism and Substrate to Ablate Persistent Atrial Fibrillation Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2015-09-14","conditions":["Persistent Atrial Fibrillation"],"enrollment":52,"completionDate":"2026-01-31"},{"nctId":"NCT03504956","phase":"NA","title":"Coronary Atherosclerosis T1-Weighted Characterization (CATCH)","status":"RECRUITING","sponsor":"Cedars-Sinai Medical Center","startDate":"2018-07-30","conditions":["Coronary Atherosclerosis"],"enrollment":150,"completionDate":"2026-12-31"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"route":"Oral"},"crossReferences":{"UNII":"CPD4NFA903","SPL_ID":"28bfacec-d5ea-4620-86c1-76c2d6200295","chemblId":"CHEMBL3544910"},"formularyStatus":[],"_enricherVersion":"v2-openfda","developmentCodes":[],"ownershipHistory":[{"period":"","companyName":"BioActive Nutritional, Inc.","relationship":"Original Developer"}],"publicationCount":32411,"therapeuticAreas":["Neuroscience"],"biosimilarFilings":[],"originalDeveloper":"BioActive Nutritional, Inc.","recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"BioActive Nutritional, Inc.","companyId":"bioactive-nutritional-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":8,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:18:18.867312+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}